Selectis Health (GBCS) Net Income towards Common Stockholders (2010 - 2025)

Selectis Health has disclosed Net Income towards Common Stockholders across 16 years of filings, most recently posting -$811621.0 for Q4 2025.

• Net Income towards Common Stockholders for Q4 2025 came in at -$811621.0, down 40.79% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.1 million (up 56.95% YoY), and the FY2025 annual result was -$1.1 million, up 56.95% from the prior year.
• Net Income towards Common Stockholders came in at -$811621.0 for Q4 2025 at Selectis Health, down from $744865.0 in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $4.0 million in Q1 2023 to a low of -$3.6 million in Q4 2023.
• The 5-year median for Net Income towards Common Stockholders is -$674874.5 (2021), against an average of -$586584.3.
• Across the five-year window, Net Income towards Common Stockholders plunged 1784.11% in 2022 and surged 1656.91% in 2023, its largest moves.
• Selectis Health's Net Income towards Common Stockholders stood at -$1.8 million in 2021, then fell by 22.32% to -$2.2 million in 2022, then slumped by 65.5% to -$3.6 million in 2023, then soared by 84.17% to -$576463.0 in 2024, then tumbled by 40.79% to -$811621.0 in 2025.
• The last three Net Income towards Common Stockholders figures came in at -$811621.0 (Q4 2025), $744865.0 (Q3 2025), and -$315527.0 (Q2 2025), per Business Quant data.